-+ 0.00%
-+ 0.00%
-+ 0.00%

THERATECHNOLOGIES RECEIVES FDA APPROVAL FOR EGRIFTA WR™ (TESAMORELIN F8) TO TREAT EXCESS VISCERAL ABDOMINAL FAT IN ADULTS WITH HIV AND LIPODYSTROPHY

Reuters·03/25/2025 21:45:00

Please log in to view news